A research team has developed a single-dose CRISPR-CasRx nanotherapy targeting the host enzyme cathepsin L (referred to as SCNC) that not only reduces SARS-CoV-2 viral load during acute infection but ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively cured through the use of CRISPR gene editing technology. But the rollout of ...
CRISPR Therapeutics (CRSP) earns a Hold rating as pipeline breadth grows but CASGEVY's launch remains slow and economically unattractive. CRSP’s in vivo editing platform shows strong early validation, ...
CRISPR powers everything from gene editing to rapid diagnostics, but how did one of its most versatile branches arise? A new Cell study, “Functional RNA splitting drove the evolutionary emergence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results